Innovative Type 1 Diabetes Approach Licensed to Encellin
Encellin obtained exclusive rights from UCSF for a proprietary cell encapsulation technology aimed at improving physicians’ ability to perform cell transplants without the need for immunosuppressive drugs.
![](/sites/default/files/styles/news_card__image/public/fields/field_insert_file/news/Encellin_device.jpg)